medline.ch Gastroenterologie Magen-Darm Neoplasie

	NSUN2 as an emerging epigenetic regulator in cancer: from biomarker to therapeutic target. RNA Biol Wei Y, Xu W, Bi Y, Guo Q, Song P, Sun Y, Guo F, Gu P, Han Y. PMID: 41937349 [PubMed - as supplied by publisher]
	Global burden of cancer in children and adolescents aged 0-19 years, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet GBD 2023 Childhood Cancer Collaborators. PMID: 41936367 [PubMed - indexed for MEDLINE]
	Finding the right time to initiate exercise rehabilitation following a cancer diagnosis: A systematic review and meta-analysis. Physiotherapy Tan GA, Peiris CL, Taylor NF, Harding KE, Dennett AM. PMID: 41936186 [PubMed - as supplied by publisher]
	Confocal Laser Endomicroscopy in the Diagnosis of Pharyngeal Neoplasms: An Optical Biopsy Approach. Gastrointest Endosc Chen Y, Zhang Y, Zhao Q, Zhou F, Ge L. PMID: 41935673 [PubMed - as supplied by publisher]
	The role of ctDNA in precision adjuvant therapy for colorectal cancer: a scoping review. J Gastrointest Surg Jiang T, Chen L, Shen Y, Meng W, Chen H, Wang Z. PMID: 41935608 [PubMed - as supplied by publisher]
	A CT-based model integrating deep learning features radiomics and body composition for preoperative prediction of microsatellite instability in colorectal cancer: a multicenter study. Eur J Radiol Han K, Zhu C, Xu Z, Ouyang Y, He D, He X, Huang L, Fang T, Xu Z, Yang Y. PMID: 41935453 [PubMed - as supplied by publisher]
	CEST-MRI assessment of locally advanced pMMR rectal cancer for prediction of immune activation status following radiotherapy. Eur Radiol Jin Z, Zhang L, Zheng C, Yang F, Hao N, Mao L, Chi B, Liu Y, Sun P, Zheng N, Wang H, Lin Z, Li X. PMID: 41935245 [PubMed - as supplied by publisher]
	Neoadjuvant FOLFOXIRI chemotherapy with or without camrelizumab in the treatment of locally advanced rectal cancer: a retrospective cohort study. NPJ Precis Oncol Liu Y, Zhao S, Du F, Du S, Song L, Xia T, Zhang B, Cui B. PMID: 41935188 [PubMed - as supplied by publisher]
	Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial. Nat Commun Capdevila J, Hernando J, Molina-Cerillo J, Plana Serrahima M, Taberna Sanz M, Castelo B, Álvarez-Escolá C, Carmona-Bayonas A, Ballester Navarro I, Iglesias L, Bover M, Garcia-Alvarez A, Lavernia J, Yayá Tur R, Ruiz S, Baste N, Lorenzo-Lorenzo I, Sanchez-Hernandez A, Sanz-Garcia E, Marquina G, Nuciforo P, Elguero B, Grande E, Alonso-Gordoa T. PMID: 41935063 [PubMed - as supplied by publisher]
	Simultaneous microwave ablation and liver resection in patients with colorectal liver metastases. HPB (Oxford) Yu H, Reider L, Asenbaum U, Waneck F, Schwarz C, Kaczirek K, Stremitzer S. PMID: 41934995 [PubMed - indexed for MEDLINE]
	Comparative efficacy and safety of nivolumab-based combination therapies (with ipilimumab or binimetinib) in patients with microsatellite-stable and microsatellite-instability-high metastatic colorectal cancer: a systematic review and meta-analysis. Clin Transl Oncol Abbas H, Ahmed H, Shuja H, Ahmed GU, Muskan FNU, Khiani RK, Wamiq U, Abdullah A, Sabahat SE, Ghori AK, Jafry SSH, Raza ML. PMID: 41934582 [PubMed - as supplied by publisher]
	Systemic inflammation and body composition profiles are dependent on ethnicity in colorectal cancer. Support Care Cancer Pring ET, Gould LE, Malietzis G, Lung P, Drami I, Mai DVC, Rai J, Athanasiou T, Jenkins JT. PMID: 41934505 [PubMed - indexed for MEDLINE]
	Integrating Prostate-Specific Antigen Density and Prostate Imaging Reporting and Data System Scores to Optimize Detection of Clinically Significant Prostate Cancer: A Multivariable Risk Model Approach. J Clin Lab Anal Kayali Y. PMID: 41934174 [PubMed - as supplied by publisher]
	Harnessing Isorhamnetin for Gastrointestinal Cancers: Molecular Mechanisms and Therapeutic Potential. J Biochem Mol Toxicol Koli D, Sheokand A, Sharma G, Tuli HS, Pahwa R. PMID: 41934157 [PubMed - indexed for MEDLINE]
	Recent Advancements of Neoadjuvant Strategies in Locally Advanced Rectal Cancer. Crit Rev Oncol Hematol Zhou J, Li J, Zhu X, Hong L, Chen W, Tan J, Guo H, Chen K. PMID: 41933857 [PubMed - as supplied by publisher]
	Integrated singleâ€‘cell and spatial transcriptomics reveal the colorectal cancer microenvironment. Crit Rev Oncol Hematol Yang R, Hu S, Li K, Wang H, Zhou X, Han T, Guan L. PMID: 41933856 [PubMed - as supplied by publisher]
	TWIST1 mediated transcriptional activation of SPON2 drives colorectal cancer peritoneal metastasis through stromal cell signaling network. Oncogene Zhou Z, La Ferlita A, Palavalli MH, Chen X, Tyler L, Ejaz A, Beane J, Polanco PM, Huang H, Kim AC. PMID: 41933135 [PubMed - as supplied by publisher]
	TMEM184A promotes progression and drug resistance in colorectal cancer: a bioinformatics and clinical study. Sci Rep Bai X, Bai Z, Bu P, Liu R, Zhao G, Cui W, Cui Y, Xi Y. PMID: 41932993 [PubMed - as supplied by publisher]
	Organ preservation with total neoadjuvant therapy in early-stage rectal cancer: A statewide analysis. Colorectal Dis Bunjo Z, Fitzsimmons T, Nguyen TM, Penniment M, Selva-Nayagam S, Tonkin D, Sia TC, Murphy E, Thomas M, Sammour T. PMID: 41932842 [PubMed - indexed for MEDLINE]
	A universal threshold of 10â€‰Î¼g/g for faecal haemoglobin (f-Hb) in isolation does not meet the aims of NICE guidance in the urgent suspected colorectal cancer pathway. Colorectal Dis Cripps NPJ, Osborne D, Joshi S. PMID: 41932829 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 238244

Seite 1 von 11913



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung